SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 31 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,158 | -51.8% | 56,140 | 0.0% | 0.00% | – |
| Q1 2023 | $31,438 | -62.2% | 56,140 | -50.0% | 0.00% | – |
| Q4 2022 | $83,088 | -35.1% | 112,280 | +100.0% | 0.00% | – |
| Q3 2022 | $128,000 | -28.5% | 56,140 | 0.0% | 0.00% | – |
| Q2 2022 | $179,000 | -89.5% | 56,140 | -84.1% | 0.00% | – |
| Q1 2022 | $1,697,000 | -45.8% | 352,904 | +0.7% | 0.00% | – |
| Q4 2021 | $3,131,000 | -33.6% | 350,617 | +7.2% | 0.00% | – |
| Q3 2021 | $4,718,000 | +14.2% | 327,212 | +14.4% | 0.00% | – |
| Q2 2021 | $4,132,000 | +344.8% | 285,928 | +321.0% | 0.00% | – |
| Q1 2021 | $929,000 | -42.0% | 67,921 | +22.8% | 0.00% | – |
| Q4 2020 | $1,603,000 | – | 55,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NanoDimension, Inc. | 1,445,221 | $4,596,000 | 15.05% |
| 683 Capital Management, LLC | 2,157,738 | $6,861,000 | 0.48% |
| Artal Group S.A. | 1,606,309 | $5,108,000 | 0.27% |
| Sandy Cove Advisors, LLC | 51,707 | $164,000 | 0.15% |
| MAVERICK CAPITAL LTD | 1,068,155 | $3,397,000 | 0.08% |
| ACT CAPITAL MANAGEMENT, LLC | 16,000 | $51,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $8,005,000 | 0.05% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $8,770,977 | 0.05% |
| Laurion Capital Management LP | 431,400 | $1,372,000 | 0.02% |
| RBF Capital, LLC | 80,000 | $254,000 | 0.02% |